Skip to Main Content

3,139

Views

7

CrossRef citations to date

0

Altmetric

Articles

Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy

Peter A. Lioa Feinberg School of Medicine, Northwestern University, Chicago, IL, USACorrespondence[email protected]
View further author information

,

Eric L. Simpsonb Oregon Health and Science University, Portland, OR, USAView further author information

,

George Hanc Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

,

Jennifer Soungd Southern California Dermatology, Inc, Santa Ana, CA, USAView further author information

,

Susan Balle Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Luna Sune Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Marta Casillase Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Amy M. DeLoziere Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Yuxin Dinge Eli Lilly and Company, Indianapolis, IN, USAView further author information

&

Lawrence F. Eichenfieldf University of California San Diego, San Diego, CA, USA;g Rady Children’s Hospital, San Diego, CA, USAView further author information